HI
CHRS icon

Harbour Investments’s Coherus Oncology CHRS Stock Holding History

Harbour Investments’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100
Closed -$104 – 3501
2024
Q3 		$104 Hold
100
– – ﹤0.01% 3311
2024
Q2 		$173 Hold
100
– – ﹤0.01% 3171
2024
Q1 		$239 Hold
100
– – ﹤0.01% 3098
2023
Q4 		$333 Sell
100
-90
-47% -$241 ﹤0.01% 2980
2023
Q3 		$711 Buy
190
+100
+111% +$462 ﹤0.01% 2754
2023
Q2 		$384 Buy
+90
New +$531 ﹤0.01% 2844

Other funds holding CHRS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Harbour Investments's CHRS Position: Q4 2024 in Review

Harbour Investments sold out of Coherus Oncology (CHRS) in Q4 2024, closing a stake of 100 shares — an estimated $104 sold.

Harbour Investments first reported a position in CHRS in Q2 2023 and held it in 6 quarters. The position peaked at $711 in Q3 2023. 124 funds tracked by Wall St. Rank hold CHRS as of Q4 2024.

  • Harbour Investments reported no remaining Coherus Oncology position as of Q4 2024 after selling out during the quarter.
  • Harbour Investments sold 100 Coherus Oncology shares in Q4 2024, an estimated $104.
  • Harbour Investments first reported a position in Coherus Oncology in Q2 2023 and held it in 6 quarters.
  • Harbour Investments's Coherus Oncology position peaked at $711 in Q3 2023.
  • 124 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2024.

Based on Harbour Investments's 13F filing for Q4 2024, filed 10 Feb 2025.